Kyle Moran

CIK: 0001657765

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (38.1%)

Position reduction

Option Exercises (M)6 (28.6%)

Derivative conversions

Awards (A)7 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

WVE

Wave Life Sciences Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (21 total)

WVE
Wave Life Sciences Ltd.
Feb 9, 2026
Sale(S)
Direct
3.6K shares at avg. $13.45$48K
WVE
Wave Life Sciences Ltd.
Feb 5, 2026
Award(A)
Direct
45.6K shares-
WVE
Wave Life Sciences Ltd.
Dec 9, 2025
Award(A)
Share Option (right to buy)
Direct
50K shares-
WVE
Wave Life Sciences Ltd.
Dec 9, 2025
Exercise(M)
Direct
36K shares at avg. $8.17$294K
WVE
Wave Life Sciences Ltd.
Dec 9, 2025
Sale(S)
Direct
36 shares at avg. $20.25$729
WVE
Wave Life Sciences Ltd.
Dec 9, 2025
Exercise(M)
Direct
50K shares at avg. $10.48$524K
WVE
Wave Life Sciences Ltd.
Dec 9, 2025
Sale(S)
Direct
50K shares at avg. $20.02$1.0M
WVE
Wave Life Sciences Ltd.
Dec 9, 2025
Award(A)
Share Option (right to buy)
Direct
36K shares-
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Exercise(M)
Direct
50K shares at avg. $4.75$238K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Sale(S)
Direct
50K shares at avg. $18.00$900K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Award(A)
Share Option (right to buy)
Direct
60K shares-
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Award(A)
Share Option (right to buy)
Direct
100K shares-
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Award(A)
Share Option (right to buy)
Direct
50K shares-
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Exercise(M)
Direct
100K shares at avg. $3.14$314K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Sale(S)
Direct
50K shares at avg. $15.00$750K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Sale(S)
Direct
50K shares at avg. $13.20$660K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Exercise(M)
Direct
60K shares at avg. $2.83$170K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Sale(S)
Direct
60K shares at avg. $13.20$792K
WVE
Wave Life Sciences Ltd.
Feb 4, 2025
Award(A)
Direct
42K shares-
WVE
Wave Life Sciences Ltd.
Oct 11, 2024
Exercise(M)
Direct
25K shares at avg. $2.48$62K
WVE
Wave Life Sciences Ltd.
Sep 25, 2024
Sale(S)
Direct
17.1K shares at avg. $9.00$154K

		Type	Shares	Price		Ownership
Feb 9, 2026	WVE Wave Life Sciences Ltd.	Sale(S)	3,588	$13.45	$48,259	Direct
Feb 5, 2026	WVE Wave Life Sciences Ltd.	Award(A)	45,625	-	$0	Direct
Dec 9, 2025	WVE Wave Life Sciences Ltd.	Award(A) Share Option (right to buy)	50,000	-	-	Direct
Dec 9, 2025	WVE Wave Life Sciences Ltd.	Exercise(M)	36,000	$8.17	$294,120	Direct
Dec 9, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	36	$20.25	$729	Direct
Dec 9, 2025	WVE Wave Life Sciences Ltd.	Exercise(M)	50,000	$10.48	$524,000	Direct
Dec 9, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	50,000	$20.02	$1,001,250	Direct
Dec 9, 2025	WVE Wave Life Sciences Ltd.	Award(A) Share Option (right to buy)	36,000	-	-	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Exercise(M)	50,000	$4.75	$237,500	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	50,000	$18.00	$900,000	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Award(A) Share Option (right to buy)	60,000	-	-	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Award(A) Share Option (right to buy)	100,000	-	-	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Award(A) Share Option (right to buy)	50,000	-	-	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Exercise(M)	100,000	$3.14	$314,000	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	50,000	$15.00	$750,000	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	50,000	$13.20	$660,000	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Exercise(M)	60,000	$2.83	$169,800	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	60,000	$13.20	$792,000	Direct
Feb 4, 2025	WVE Wave Life Sciences Ltd.	Award(A)	42,000	-	-	Direct
Oct 11, 2024	WVE Wave Life Sciences Ltd.	Exercise(M)	25,000	$2.48	$62,000	Direct
Sep 25, 2024	WVE Wave Life Sciences Ltd.	Sale(S)	17,146	$9.00	$154,314	Direct

1-21 of 21 transactions

About Moran Kyle

Moran Kyle (SEC CIK 0001657765) files insider reports with the SEC as Chief Financial Officer of Wave Life Sciences Ltd. (WVE).

Signal8 holds 5 ownership filings by Moran Kyle, all Form 4s, filed between Sep 27, 2024 and Feb 11, 2026. Those filings report 21 transactions, from Sep 25, 2024 to Feb 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Moran Kyle's filings is in CAMBRIDGE, MA.

Recent filings by Moran Kyle

Feb 9, 2026: Open-market sale of WVE shares (Form 4, code S).
Feb 5, 2026: Grant or award of WVE shares (Form 4, code A).
Dec 9, 2025: Grant or award of WVE derivative securities (Form 4, code A).
Dec 9, 2025: Option exercise of WVE shares (Form 4, code M).
Dec 9, 2025: Open-market sale of WVE shares (Form 4, code S).

Other insiders filing for Wave Life Sciences Ltd. (WVE)

RA CAPITAL MANAGEMENT, L.P., Director
Verdine Gregory L., Director
Tan Aik Na, Director
TAKANASHI KEN, Director
CORRIGAN MARK, Director
Rawcliffe Adrian, Director

How to read Form 4 transaction codes